Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Laboratory Medicine"
DOI: 10.3343/alm.2018.38.6.563
Abstract: Background Delamanid, bedaquiline, and linezolid have recently been approved for the treatment of multidrug- and extensively drug-resistant (MDR and XDR, respectively) tuberculosis (TB). To use these drugs effectively, drug susceptibility tests, including rapid molecular techniques,… read more here.
Keywords: delamanid bedaquiline; resistance related; bedaquiline linezolid; drug ... See more keywords
Erratum: Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Laboratory Medicine"
DOI: 10.3343/alm.2019.39.1.113
Abstract: This corrects the article on p. 563 in vol. 38, PMID: 30027700. read more here.
Keywords: delamanid bedaquiline; linezolid minimum; minimum inhibitory; bedaquiline linezolid ... See more keywords